Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial

We conducted a phase III study to test the hypothesis that initial therapy with “lower dose” prednisone is effective and safe for patients with newly diagnosed acute graft-versus-host disease. We hypothesized that a 50% decrease in the initial dose of prednisone for treatment of acute graft-versus-h...

Full description

Bibliographic Details
Published in:Haematologica
Main Authors: Marco Mielcarek, Terrence Furlong, Barry E. Storer, Margaret L. Green, George B. McDonald, Paul A. Carpenter, Mary E.D. Flowers, Rainer Storb, Michael Boeckh, Paul J. Martin
Format: Article
Language:English
Published: Ferrata Storti Foundation 2015-06-01
Online Access:https://haematologica.org/article/view/7415
_version_ 1850287600777035776
author Marco Mielcarek
Terrence Furlong
Barry E. Storer
Margaret L. Green
George B. McDonald
Paul A. Carpenter
Mary E.D. Flowers
Rainer Storb
Michael Boeckh
Paul J. Martin
author_facet Marco Mielcarek
Terrence Furlong
Barry E. Storer
Margaret L. Green
George B. McDonald
Paul A. Carpenter
Mary E.D. Flowers
Rainer Storb
Michael Boeckh
Paul J. Martin
author_sort Marco Mielcarek
collection DOAJ
container_title Haematologica
description We conducted a phase III study to test the hypothesis that initial therapy with “lower dose” prednisone is effective and safe for patients with newly diagnosed acute graft-versus-host disease. We hypothesized that a 50% decrease in the initial dose of prednisone for treatment of acute graft-versus-host disease would suffice to control graft-versus-host disease without increasing the incidence of secondary treatment. Patients with grade IIa manifestations (upper gastrointestinal symptoms, stool volumes
format Article
id doaj-art-070d2cbc655c42eabf37d087f702e62d
institution Directory of Open Access Journals
issn 0390-6078
1592-8721
language English
publishDate 2015-06-01
publisher Ferrata Storti Foundation
record_format Article
spelling doaj-art-070d2cbc655c42eabf37d087f702e62d2025-08-19T23:36:51ZengFerrata Storti FoundationHaematologica0390-60781592-87212015-06-01100610.3324/haematol.2014.118471Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trialMarco Mielcarek0Terrence Furlong1Barry E. Storer2Margaret L. Green3George B. McDonald4Paul A. Carpenter5Mary E.D. Flowers6Rainer Storb7Michael Boeckh8Paul J. Martin9Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA;University of Washington, Seattle, WA, USAClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USAClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA;University of Washington, Seattle, WA, USAUniversity of Washington, Seattle, WA, USA;Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USAClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA;University of Washington, Seattle, WA, USAClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA;University of Washington, Seattle, WA, USAClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA;University of Washington, Seattle, WA, USAClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA;University of Washington, Seattle, WA, USAUniversity of Washington, Seattle, WA, USA;Vaccines and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USAClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA;University of Washington, Seattle, WA, USAWe conducted a phase III study to test the hypothesis that initial therapy with “lower dose” prednisone is effective and safe for patients with newly diagnosed acute graft-versus-host disease. We hypothesized that a 50% decrease in the initial dose of prednisone for treatment of acute graft-versus-host disease would suffice to control graft-versus-host disease without increasing the incidence of secondary treatment. Patients with grade IIa manifestations (upper gastrointestinal symptoms, stool volumes https://haematologica.org/article/view/7415
spellingShingle Marco Mielcarek
Terrence Furlong
Barry E. Storer
Margaret L. Green
George B. McDonald
Paul A. Carpenter
Mary E.D. Flowers
Rainer Storb
Michael Boeckh
Paul J. Martin
Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial
title Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial
title_full Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial
title_fullStr Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial
title_full_unstemmed Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial
title_short Effectiveness and safety of lower dose prednisone for initial treatment of acute graft-versus-host disease: a randomized controlled trial
title_sort effectiveness and safety of lower dose prednisone for initial treatment of acute graft versus host disease a randomized controlled trial
url https://haematologica.org/article/view/7415
work_keys_str_mv AT marcomielcarek effectivenessandsafetyoflowerdoseprednisoneforinitialtreatmentofacutegraftversushostdiseasearandomizedcontrolledtrial
AT terrencefurlong effectivenessandsafetyoflowerdoseprednisoneforinitialtreatmentofacutegraftversushostdiseasearandomizedcontrolledtrial
AT barryestorer effectivenessandsafetyoflowerdoseprednisoneforinitialtreatmentofacutegraftversushostdiseasearandomizedcontrolledtrial
AT margaretlgreen effectivenessandsafetyoflowerdoseprednisoneforinitialtreatmentofacutegraftversushostdiseasearandomizedcontrolledtrial
AT georgebmcdonald effectivenessandsafetyoflowerdoseprednisoneforinitialtreatmentofacutegraftversushostdiseasearandomizedcontrolledtrial
AT paulacarpenter effectivenessandsafetyoflowerdoseprednisoneforinitialtreatmentofacutegraftversushostdiseasearandomizedcontrolledtrial
AT maryedflowers effectivenessandsafetyoflowerdoseprednisoneforinitialtreatmentofacutegraftversushostdiseasearandomizedcontrolledtrial
AT rainerstorb effectivenessandsafetyoflowerdoseprednisoneforinitialtreatmentofacutegraftversushostdiseasearandomizedcontrolledtrial
AT michaelboeckh effectivenessandsafetyoflowerdoseprednisoneforinitialtreatmentofacutegraftversushostdiseasearandomizedcontrolledtrial
AT pauljmartin effectivenessandsafetyoflowerdoseprednisoneforinitialtreatmentofacutegraftversushostdiseasearandomizedcontrolledtrial